Baudax Bio Inc (BXRXQ)

Currency in USD
0.0001
0.0000(0.00%)
Closed·
BXRXQ Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week Low
Fair Value
Day's Range
0.00010.0001
52 wk Range
0.00010.0002
Key Statistics
Prev. Close
-
Open
0.0001
Day's Range
0.0001-0.0001
52 wk Range
0.0001-0.0002
Volume
-
Average Volume (3m)
7.15K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BXRXQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Baudax Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Baudax Bio Inc Company Profile

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.

Compare BXRXQ to Peers and Sector

Metrics to compare
BXRXQ
Peers
Sector
Relationship
P/E Ratio
0.0x−0.8x−0.5x
PEG Ratio
0.00−0.070.00
Price/Book
0.0x−0.1x2.6x
Price / LTM Sales
0.0x2.1x3.3x
Upside (Analyst Target)
0.0%180.6%43.5%
Fair Value Upside
Unlock5.3%6.3%Unlock

Earnings

Latest Release
Nov 20, 2023
EPS / Forecast
-0.29 / -0.53
Revenue / Forecast
-- / 240.00K
EPS Revisions
Last 90 days

BXRXQ Income Statement

FAQ

What Stock Exchange Does Baudax Bio Trade On?

Baudax Bio is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Baudax Bio?

The stock symbol for Baudax Bio is "BXRXQ."

What Is the Baudax Bio Market Cap?

As of today, Baudax Bio market cap is 5.25K.

What Is Baudax Bio's Earnings Per Share (TTM)?

The Baudax Bio EPS (TTM) is -14.85.

From a Technical Analysis Perspective, Is BXRXQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Baudax Bio Stock Split?

Baudax Bio has split 2 times.

How Many Employees Does Baudax Bio Have?

Baudax Bio has 9 employees.

What is the current trading status of Baudax Bio (BXRXQ)?

As of 05 Aug 2025, Baudax Bio (BXRXQ) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.